Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma [Phase 3]
A Phase III clinical trial evaluating concurrent chemotherapy alone in low-risk nasopharyngeal carcinoma is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma. [NA]
A clinical trial comparing endoscopic surgery versus intensity-modulated radiotherapy for Stage I nasopharyngeal carcinoma is currently recr…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma. [NA]
This clinical trial compares two chemoradiotherapy regimens combined with surgery for newly diagnosed operable nasopharyngeal carcinoma. The…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
A multicenter study in China is investigating features of the gut microbiota in patients with several chronic diseases and is currently recr…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Distribution of Bacteria in OME After Radiotherapy For NPC.
This clinical trial update describes the distribution of bacteria in otitis media with effusion after radiotherapy in patients with nasophar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial is evaluating penpulimab with the GP chemotherapy regimen, with or without anlotinib, as neoadjuvant therapy for locoregiona…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma [Phase 3]
This clinical trial update describes an ongoing Phase 3 study of online adaptive radiotherapy for nasopharyngeal carcinoma, which is current…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Hearing Impairment of Nasopharyngeal Carcinoma
A completed clinical trial studied hearing impairment in patients with nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis. [Phase 3]
A Phase 3 trial evaluating tislelizumab in combination with GP or TPC regimens for nasopharyngeal carcinoma with bone metastasis is currentl…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial [Phase 3]
A Phase 3 clinical trial update comparing TPC+Apatinib+Camrelizumab versus GP+Camrelizumab in high-risk nasopharyngeal carcinoma to assess e…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating induction therapy with gemcitabine plus cisplatin in combination with nimotuzumab and sintilimab for locally advanc…
-
CLINICAL_TRIALS other · 2024-07-08Clinical Trial Update: TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial comparing TPC induction chemotherapy to GP induction chemotherapy for nasopharyngeal carcinoma is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) [Phase 1]
This update reports the completion of a Phase 1 study (DUET-3) evaluating XmAb23104 in patients with selected advanced solid tumors.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. [Phase 3]
Phase III open, randomized trial evaluating PFLL with a PD-1 antibody, with or without fecal microbiota transplantation, for oligometastatic…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy
This clinical trial update describes an exploratory study to assess clearance of Epstein-Barr Virus DNA titres in patients with nasopharynge…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study [NA]
This clinical trial update describes a study evaluating manual acupuncture for radiotherapy-induced mucositis in nasopharyngeal carcinoma, u…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial comparing GP plus adebrelimab versus GP neoadjuvant chemotherapy for nasopharyngeal carcinoma is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy [Phase 2]
This Phase 2 trial, sponsored by Sun Yat-sen University, is evaluating whether GM-CSF can prevent oral mucositis in patients with nasopharyn…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
This clinical trial is evaluating the diagnostic accuracy of an EBV C promoter methylation kit for nasopharyngeal carcinoma and is currently…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC [Phase 2]
Phase II trial update from Shanghai Henlius Biotech evaluating HLX07 + serplulimab + chemotherapy versus placebo + serplulimab + chemotherap…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal Carcinoma [NA]
This clinical trial update notes the completion of a study evaluating oral enteral nutrition to manage delayed onset radiotherapy-related sw…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients [NA]
This entry notes a clinical trial investigating a combination of anti-IL6R therapy and anticoagulation in advanced nasopharyngeal carcinoma,…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11 [Phase 2]
This Phase 2 trial evaluating nivolumab plus gemcitabine for recurrent or metastatic nasopharyngeal carcinoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Nivolumab in Children and Adults With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating nivolumab in children and adults with nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study [NA]
This clinical trial update reports completion of a feasibility and planning study that uses 18F-FMISO PET imaging to guide dose escalation i…